These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32141701)

  • 1. FAM46C controls antibody production by the polyadenylation of immunoglobulin mRNAs and inhibits cell migration in multiple myeloma.
    Herrero AB; Quwaider D; Corchete LA; Mateos MV; García-Sanz R; Gutiérrez NC
    J Cell Mol Med; 2020 Apr; 24(7):4171-4182. PubMed ID: 32141701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma.
    Mroczek S; Chlebowska J; Kuliński TM; Gewartowska O; Gruchota J; Cysewski D; Liudkovska V; Borsuk E; Nowis D; Dziembowski A
    Nat Commun; 2017 Sep; 8(1):619. PubMed ID: 28931820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of
    Zhu YX; Shi CX; Bruins LA; Jedlowski P; Wang X; Kortüm KM; Luo M; Ahmann JM; Braggio E; Stewart AK
    Cancer Res; 2017 Aug; 77(16):4317-4327. PubMed ID: 28619709
    [No Abstract]   [Full Text] [Related]  

  • 4. FAM46C and FNDC3A Are Multiple Myeloma Tumor Suppressors That Act in Concert to Impair Clearing of Protein Aggregates and Autophagy.
    Manfrini N; Mancino M; Miluzio A; Oliveto S; Balestra M; Calamita P; Alfieri R; Rossi RL; Sassoè-Pognetto M; Salio C; Cuomo A; Bonaldi T; Manfredi M; Marengo E; Ranzato E; Martinotti S; Cittaro D; Tonon G; Biffo S
    Cancer Res; 2020 Nov; 80(21):4693-4706. PubMed ID: 32963011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biallelic loss of FAM46C triggers tumor growth with concomitant activation of Akt signaling in multiple myeloma cells.
    Kanasugi J; Hanamura I; Ota A; Karnan S; Lam VQ; Mizuno S; Wahiduzzaman M; Rahman ML; Hyodo T; Konishi H; Tsuzuki S; Hosokawa Y; Takami A
    Cancer Sci; 2020 May; 111(5):1663-1675. PubMed ID: 32176823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Interaction of the Tumor Suppressor FAM46C with p62 and FNDC3 Proteins Integrates Protein and Secretory Homeostasis.
    Fucci C; Resnati M; Riva E; Perini T; Ruggieri E; Orfanelli U; Paradiso F; Cremasco F; Raimondi A; Pasqualetto E; Nuvolone M; Rampoldi L; Cenci S; Milan E
    Cell Rep; 2020 Sep; 32(12):108162. PubMed ID: 32966780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional characterization of multiple myeloma associated cytoplasmic poly(A) polymerase FAM46C.
    Zhang H; Zhang SH; Hu JL; Wu YT; Ma XY; Chen Y; Yu B; Liao S; Huang H; Gao S
    Cancer Commun (Lond); 2021 Jul; 41(7):615-630. PubMed ID: 34048638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and Functional Analyses of the FAM46C/Plk4 Complex.
    Chen H; Lu D; Shang G; Gao G; Zhang X
    Structure; 2020 Aug; 28(8):910-921.e4. PubMed ID: 32433990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of miR-10b represses cell vitality in osteosarcoma and is inversely associated with prognosis via interacting with FAM46C: Running title: MiR-10b/FAM46C axis modulates OS progression.
    Gao XZ; Xi XF; Zhang SP
    Tissue Cell; 2020 Apr; 63():101331. PubMed ID: 32223957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-canonical RNA polyadenylation polymerase FAM46C is essential for fastening sperm head and flagellum in mice†.
    Zheng C; Ouyang YC; Jiang B; Lin X; Chen J; Dong MZ; Zhuang X; Yuan S; Sun QY; Han C
    Biol Reprod; 2019 Jun; 100(6):1673-1685. PubMed ID: 31087039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Immunity-malignancy equilibrium in multiple myeloma: lessons from oncogenic events in plasma cells.
    Perini T; Materozzi M; Milan E
    FEBS J; 2022 Aug; 289(15):4383-4397. PubMed ID: 34117720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-657 Promotes Macrophage Polarization toward M1 by Targeting FAM46C in Gestational Diabetes Mellitus.
    Wang P; Wang Z; Liu G; Jin C; Zhang Q; Man S; Wang Z
    Mediators Inflamm; 2019; 2019():4851214. PubMed ID: 31915414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 mediated knock-out of VPREB1 gene induces a cytotoxic effect in myeloma cells.
    Khaled M; Moustafa AS; El-Khazragy N; Ahmed MI; Abd Elkhalek MA; El Salahy EM
    PLoS One; 2021; 16(1):e0245349. PubMed ID: 33418558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma.
    Zhang W; Wu C; Geng S; Wang J; Yan C; Zhang X; Zhang JJ; Wu F; Pang Y; Zhong Y; Wang J; Fu W; Huang X; Wang W; Lyu X; Huang Y; Jing H
    Aging (Albany NY); 2023 May; 15(9):3644-3677. PubMed ID: 37155154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol inhibits proliferation, migration and invasion of multiple myeloma cells via NEAT1-mediated Wnt/β-catenin signaling pathway.
    Geng W; Guo X; Zhang L; Ma Y; Wang L; Liu Z; Ji H; Xiong Y
    Biomed Pharmacother; 2018 Nov; 107():484-494. PubMed ID: 30107344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the Puzzling Roles of FAM46C: A Multifaceted Pan-Cancer Tumour Suppressor with Increasing Clinical Relevance.
    Lai G; De Grossi F; Catusi I; Pesce E; Manfrini N
    Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730656
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Araújo T; Khayat A; Quintana L; Calcagno D; Mourão R; Modesto A; Paiva J; Lima A; Moreira F; Oliveira E; Souza M; Othman M; Liehr T; Abdelhay E; Gomes R; Santos S; Assumpção P
    World J Gastroenterol; 2018 Dec; 24(47):5338-5350. PubMed ID: 30598579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthesis and processing of the messenger RNAs specifying heavy and light chain immunoglobulins in MPC-11 cells.
    Schibler U; Marcu KB; Perry RP
    Cell; 1978 Dec; 15(4):1495-509. PubMed ID: 103631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells.
    Zhang QY; Yue XQ; Jiang YP; Han T; Xin HL
    Sci Rep; 2017 Mar; 7(1):396. PubMed ID: 28341836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and use of the novel human multiple myeloma cell line MC-B11/14 to study biological consequences of CRISPR-mediated loss of immunoglobulin A heavy chain.
    Walters DK; Arendt BK; Tschumper RC; Wu X; Jelinek DF
    Exp Hematol; 2018 Jan; 57():42-49.e1. PubMed ID: 29030084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.